T6609 |
NMS-E973
|
1253584-84-7
|
99.82%
|
|
NMS-E973 is a potent and selective Hsp90 inhibitor with DC50 of <10 nM for Hsp90 binding, no activiy against a panel of 52 diverse protein kinases.
|
T13553 |
Arimoclomol
|
289893-25-0
|
99.81%
|
|
Arimoclomol (BRX-220 free base) is a co-inducer of heat shock proteins (HSP) and can be used in studies about the treatment of amyotrophic lateral sclerosis (ALS...
|
T9202 |
DDO-5936
|
2355377-13-6
|
99.69%
|
|
DDO-5936 is a potent and specific HSP90-Cdc37 PPI inhibitor.
|
T8858 |
DTHIB
|
897326-30-6
|
99.69%
|
|
DTHIB robustly inhibits the HSF1 cancer gene signature and prostate cancer cell proliferation.
|
T8829 |
2',4'-DIHYDROXYCHALCONE
|
1776-30-3
|
99.59%
|
|
2',4'-DIHYDROXYCHALCONE (2',4'-DHC) as a compound with Hsp90 inhibitory and antifungal effects
|
T67836 |
AT-533
|
908112-37-8
|
99.54%
|
|
AT-533 is a potent inhibitor of Hsp90 and HSV. AT-533 blocks the HIF-1α/VEGF/VEGFR-2 signaling pathway, leading to suppress tumor growth and angiogenesis. AT-533...
|
T16994 |
Pimitespib
|
1260533-36-5
|
99.49%
|
|
Pimitespib (TAS-116) is an ATP-competitive and highly specific HSP90α/HSP90β inhibitor (Kis: 34.7 nM and 21.3 nM, respectively).
|
T5350 |
JG-98
|
1456551-16-8
|
99.35%
|
|
JG-98 is an allosteric Hsp70 inhibitor, displays high active against the breast cancer cell lines MDA-MB-231 and MCF-7 (EC50s: 0.4/0.7 μM).
|
T6290 |
Tanespimycin
|
75747-14-7
|
99.34%
|
|
Tanespimycin (KOS 953) (17-AAG) is an inhibitor of Hsp90 that selectively inhibits BT474 tumor cell Hsp90 (IC50: 5 nM).
|
T6210 |
Pifithrin-μ
|
64984-31-2
|
99.33%
|
|
Pifithrin-μ (NSC-303580) is an inhibitor of p53 and HSP70, with neuroprotective and antitumor activity.
|
T6170 |
Elesclomol
|
488832-69-5
|
99.33%
|
|
Elesclomol (STA-4783) is an oxidative stress inducer and a highly lipophilic copper ion carrier. Elesclomol induces apoptosis in tumor cells and is used in coppe...
|
T1501 |
Rifabutin
|
72559-06-9
|
99.27%
|
|
Rifabutin (LM-427) inhibits bacterial DNA-dependent RNA polymerase, thereby suppressing the initiation of RNA formation and leading to inhibition of RNA synthesi...
|
T9804 |
NPX800
|
1693734-80-3
|
99.26%
|
|
NPX800 is an inhibitor of heat shock factor 1 (HSF1) and can be used in studies about the treatment of cancer.
|
T1989 |
Luminespib
|
747412-49-3
|
99.25%
|
|
Luminespib (VER-52296) is a new-type inhibitor of HSP90 (IC50s: 7.8/21 nM for HSP90α/β in cell free assay).
|
T3594 |
ML346
|
100872-83-1
|
99.25%
|
|
ML346 is a novel activator of Hsp70.
|
T70353 |
JG-231
|
1627126-59-3
|
99.21%
|
|
JG-231 is a JG-98 analog with anticancer activity.JG-231 inhibits the MDA-MB-231 xenograft tumor model of triple-negative breast cancer (TNBC).JG-231 inhibits th...
|
T2268 |
VER49009
|
940289-57-6
|
99.17%
|
|
VER49009 (CCT0129397) is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM).
|
T2114 |
VER-82576
|
847559-80-2
|
99.16%
|
|
VER-82576 (NVP-BEP800), a synthetic HSP90β inhibitor (IC50: 58 nM), exhibits >70-fold selectivity against Hsp90 family members Trap-1 and Grp94.
|
T67897 |
GRP78-IN-3
|
2707510-30-1
|
99.11%
|
|
GRP78-IN-3, a potent small-molecule-competitive inhibitor of Hsp70 substrate binding and is a selective Grp78 (HSPA5) inhibitor with an IC50 of 0.59 μM. GRP78-IN...
|
T6341 |
PF04929113
|
908115-27-5
|
99.06%
|
|
PF04929113 (SNX-5422) is a synthetic, novel, small molecule Hsp90 Inhibitor. As an oral formulation that demonstrates strong efficacy and tolerability, PF0492911...
|